Scheessele William John 4
4 · Humacyte, Inc. · Filed Apr 15, 2025
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Scheessele William John
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2025-04-14$1.54/sh+6,493$9,999→ 22,018 total
Signature
/s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact|2025-04-15